News
Biopharmaceutical Global Partners
Meet Pablo Cobo: KYMOS’ key opinion leader in biologics drug development Our head of Biopharmaceutical Testing Pablo Cobo, Chemistry graduate and biologics pioneer, remembers his early days at Ipsen when peptide product development was quite (...) Read more
ANIMAL CLINICAL R&D IN TIMES OF COVID-19
The COVID-19 pandemic has paralyzed many aspects of our lives. However, the R&D of new pharmaceutical products for animal health cannot stop as many human diseases posing a threat have an animal origin. KYMOS (...) Read more
Elemental impurities analysis: anticipating our clients’ needs before they need to ask
The European Pharmacopoeia implemented the ICH Q3D guideline in June 2017, ruling the need to assess for the presence of potential elemental impurities in all drug products. Now guidelines will expand to also cover (...) Read more
Immunology: Working together to prepare for the next pandemic
Now more than ever, immunology is a hot topic as we face the numerous challenges of the COVID19 pandemic. The world is patiently awaiting new therapies and vaccines to combat this disease in hopes of (...) Read more
